Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Active or latent tuberculosis increases susceptibility to COVID-19 and disease severity
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
wasabi.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
title
Active or latent tuberculosis increases susceptibility to COVID-19 and disease severity
Creator
Chen, Yu
Liu, Chang
Wang, Y
Bi, L
Bi, Lijun
Cheng, M
Cheng, Moxin
Fan, Lichao
Fleming, J
Fleming, Joy
Gu, Ye
Liu, Yongyu
Shenyang,
Wang, (
Wang, ;
Wang, Yaguo
Yanhong, ;
source
MedRxiv
abstract
Importance: Risk factors associated with COVID-19, the viral pneumonia originating in Wuhan, China, in Dec 2019, require clarification so that medical resources can be prioritized for those at highest risk of severe COVID-19 complications. Infection with M. tuberculosis (MTB), the pathogen that causes TB and latently infects ~25% of the global population, may be a risk factor for SARS-CoV-2 infection and severe COVID-19 pneumonia. Objective: To determine if latent or active TB increase susceptibility to SARS-COV-19 infection and disease severity, and lead to more rapid development of COVID-19 pneumonia. Design: An observational case-control study of 36 confirmed COVID-19 cases from Shenyang, China, conducted in Feb 2020. Final date of follow-up: Feb 29, 2020. Cases were grouped according to COVID-19 pneumonia severity (mild/moderate, severe/critical), and MTB infection status compared. Comparisons were made with MTB infection data from another case-control study on bacterial/viral pneumonia at Shenyang Chest Hospital. Setting: Multi-center study involving three primary care hospitals in Shenyang, China. Participants: 86 suspected COVID-19 cases from participating primary-care hospitals in Shenyang. All 36 SARS-CoV-2 +ve cases (based on RT-PCR assay) were included. Disease severity was assessed using the Diagnostic and Treatment Guidelines of the National Health Commission of China (v6). Mean age, 47 years (range: 25-79), gender ratio, 1:1. Exposures: Confirmed COVID-19 pneumonia. Interferon-gamma Release Assays (IGRA) were performed using peripheral blood to determine MTB infection. Main Outcome and Measures: Epidemiological, demographic, clinical, radiological, and laboratory data were collected. Comparison of MTB infection status between patients with mild/moderate and severe/critical COVID-19 pneumonia. Results: Mean age of 36 COVID-19 patients: 47 (range: 25-79); M/F: 18/18; Wuhan/Hubei connection: 42%. Mild/moderate cases: 27 (75%); severe/critical: 9 (25%). MTB infection (IGRA+ve): 13 cases (36.11%), including 7 of 9 severe/critical cases. MTB infection rate: higher in COVID-19 (36.11%) than bacterial pneumonia (20%; p=0.0047) and viral pneumonia patients (16.13%; p=0.024). MTB infection more common than other co-morbidities (36.11% vs diabetes: 25%; hypertension: 22.2%; coronary heart disease: 8.33%; COPD: 5.56%). MTB co-infection linked with disease severity (severe/critical 78% vs mild/moderate cases 22%; p=0.0049), and rate of disease progression: infection to development of symptoms (MTB+SARS-CoV-2: 6.5+/-4.2 days vs SARS-COV-2: 8.9+/-5.2 days; p=0.073); from symptom development to diagnosed as severe (MTB+SARS-CoV-2: 3.4+/-2.0 days vs SARS-COV-2: 7.5+/-0.5 days; p=0.075). Conclusions and Relevance: MTB infection likely increases susceptibility to SARS-CoV-2, and increases COVID-19 severity, but this requires validation in a larger study. MTB infection status of COVID-19 patients should be checked routinely at hospital admission.
has issue date
2020-03-16
(
xsd:dateTime
)
bibo:doi
10.1101/2020.03.10.20033795
has license
medrxiv
sha1sum (hex)
a92029e6e42de51a3b93e503d757e27b6909b991
schema:url
https://doi.org/10.1101/2020.03.10.20033795
resource representing a document's title
Active or latent tuberculosis increases susceptibility to COVID-19 and disease severity
resource representing a document's body
covid:a92029e6e42de51a3b93e503d757e27b6909b991#body_text
is
schema:about
of
covid:arg/a92029e6e42de51a3b93e503d757e27b6909b991
named entity 'susceptible'
named entity 'COVID-19'
named entity 'SARS-CoV-2'
named entity 'Patients'
named entity 'susceptibility'
named entity 'symptom'
named entity 'SARS-CoV-2'
named entity 'preprint'
named entity 'SARS-CoV-2'
named entity 'infection'
named entity 'severe'
named entity 'infection'
named entity 'Fisher's exact test'
named entity 'peer review'
named entity 'COVID'
named entity 'preprint'
named entity 'March 16, 2020'
named entity 'medRxiv'
named entity 'peer review'
named entity 'CC-BY-NC-ND 4.0'
named entity 'sputum'
named entity 'reverse-transcription polymerase chain reaction'
named entity 'risk factor'
named entity 'co-morbidities'
named entity 'SARS-CoV-2'
named entity 'medRxiv'
named entity 'peer review'
named entity 'Shenyang'
named entity 'preprint'
named entity 'preprint'
named entity 'medRxiv'
named entity 'infection'
named entity 'China'
named entity 'pneumonia'
named entity 'viral pneumonia'
named entity 'preprint'
named entity 'COVID'
named entity 'peer review'
named entity 'coronary heart disease'
named entity 'medRxiv'
named entity 'pneumonia'
named entity 'infection'
named entity 'China'
named entity 'Guangdong'
named entity 'preprint'
named entity 't-tests'
named entity 'COVID'
named entity 'IFN'
named entity 'cough'
named entity 'infection'
named entity 'SARS-CoV'
named entity 'comorbidities'
named entity 'COVID-19'
named entity 'symptom'
named entity 'diabetes'
named entity 'infection'
named entity 'peer review'
named entity 'infection'
named entity 'infection'
named entity 'bacterial pneumonia'
named entity 'National Health Commission of China'
named entity 'infection'
named entity 'copyright holder'
named entity 'viral pneumonia'
named entity 'preprint'
named entity 'preprint'
named entity 'CC-BY-NC-ND 4.0'
named entity 'preprint'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 4
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software